Grace Therapeutics, Inc. (GRCE) earnings
Quarterly and annual GRCE reports and results, each read against the price at its own news timestamp. Back to the GRCE overview →
11 measured GRCE earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Grace Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.43% | -1.43% | |
| Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update | Press release | +1.43% | -1.43% | |
| Form 10-K Grace Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-K | +2.25% | +7.21% | |
| Form 10-Q Grace Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-Q | -1.10% | -3.29% | |
| Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update | Press release | -1.10% | -3.29% | |
| Form 10-Q/A Grace Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.14% | +4.98% | |
| Form 10-Q Grace Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.98% | — | |
| Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update | Press release | +1.98% | — | |
| Form 10-Q Grace Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Grace Therapeutics Announces First Quarter 2026 Financial Results, Provides Business Update | Press release | +0.00% | — | |
| Form 10-K Grace Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-K | -0.33% | -2.33% |
Keep exploring
More GRCE: analyst actions → · SEC filings → · GRCE overview →